Cancer risk in close relatives of women with early onset breast cancer - A population-based incidence study

British Journal of Cancer

Volumn 79, Issue 3-4, 1999, Pages 673-679

  Olsen, J H ^a   Seersholm, N ^a   Boice Jr , J D ^b,c   Kruger Kjaer S ^a   Fraumeni Jr , J F ^c  

^a INSTITUTE OF CANCER EPIDEMIOLOGY   (Denmark)

^b INTERNATIONAL EPIDEMIOLOGY INSTITUTE   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Cancer susceptibility genes; Early onset breast cancer; Familial cancer; Heriditary cancer syndromes

Indexed keywords

ARTICLE; BREAST CANCER; CANCER INCIDENCE; CANCER REGISTRY; CANCER RISK; COLON CANCER; DENMARK; ENDOMETRIUM CANCER; FAMILIAL CANCER; FEMALE; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; ONSET AGE; OVARY CANCER; PRIORITY JOURNAL; PROSTATE CANCER; RELATIVE;

ADULT; AGE OF ONSET; AGED; BREAST NEOPLASMS; BREAST NEOPLASMS, MALE; COLONIC NEOPLASMS; ENDOMETRIAL NEOPLASMS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; OVARIAN NEOPLASMS; POPULATION SURVEILLANCE; REGISTRIES; RISK ASSESSMENT;

EID: 0032905697     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6690106     Document Type: Article

References (43)

1. Amos CI and Struewing JP (1993) Genetic epidemiology of epithelial ovarian cancer. Cancer 71 (suppl. 2): 566-572
2. Anderson DE and Badzioch MD (1993) Familial breast cancer risks: effects of prostate and other cancers. Cancer 72: 114-119
3. Anderson KE, Easton DF, Matthews FE and Peto J (1992) Cancer mortality in the first degree relatives of young breast cancer patients. Br J Cancer 66: 599-602
4. Bebb G, Glickman B, Gelman K and Gatti R (1997) 'At risk' for breast cancer (commentary). Lancet 349: 1784-1785
5. Boice Jr JD, Harvey E, Blettner M, Stovall M and Flannery JT (1992) Cancer in the contralateral breast after radiotherapy for breast cancer. N Engl J Med 326: 781-785
6. Claus EB, Risch NJ and Thompson WD (1990) Age at onset as an indicator of familial risk of breast cancer. Am J Epidemiol 131: 961-972
7. Claus EB, Risch NJ and Thompson WD (1991) Genetic analysis of breast cancer in the Cancer and Steroid Hormone Study. Am J Hum Genet 48: 232-242
8. Crook T, Crossland S, Crompton MR, Osin P and Gusterson BA (1997) p53 mutations in BRCA1-associated familial breast cancer. Lancet 350: 638-639
9. Danish Board of Health (1997) Cancer incidence in Denmark 1994. In Health Statistics, vol. 7. Danish Board of Health: Copenhagen
10. Eby N, Chang-Claude J and Bishop DT (1994) Familial risk and genetic susceptibility for breast cancer. Cancer Causes Control 4: 458-470
11. FitzGerald MG, MacDonald DJ, Krainer M, Hoover I, O'Neil E, Unsal H, SilvaArrieto S, Finkelstein DM, Beer-Romero P, Englert C, Sgroi DC, Smith BL, Younger JW, Garber JE, Duda RB, Mayzel KA, Isselbacher KJ, Friend SH and Haber DA (1996) Germ-line BRCA1 mutations in Jewish and non-Jewish women with early-onset breast cancer. N Engl J Med 334: 143-149
12. FitzGerald MG, Bean JM, Hegde SR, Unsal H, MacDonald DJ, Harkin DP, Finkelstein DM, Isselbacher KJ and Haber DA (1997) Heterozygous ATM mutations do not contribute to early onset of breast cancer. Nature Genet 15: 307-310
13. Ford D, Easton DF and Peto J (1995) Estimates of the gene frequency of BRCA1 and its contribution to breast and ovarian cancer incidence. Am J Hum Genet 57: 1457-1462
14. Garber JE, Goldstein AM, Kantor AF, Dreyfus MG, Fraumeni Jr JF and Li FP (1991) Follow-up study of twenty-four families with Li-Fraumeni syndrome. Cancer Res 51: 6094-6097
15. Goldgar DE, Easton DF, Cannon-Albright LA and Skolnick MH (1994) Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands. J Natl Cancer Inst 86: 1600-1608
16. Gudmundsson J, Johannesdottir G, Arason A, Bergthorsson JT, Ingvarsson S, Egilson V and Barkardottir RB (1996) Frequent occurrence of BRCA2 linkage in Icelandic breast cancer families and segregation of a common BRCA2 haplotype. Am J Hum Genet 58: 749-756
17. Inskip PD, Stovall M and Flannery JT (1994) Lung cancer risk and radiation dose among women treated for breast cancer. J Natl Cancer Inst 86: 983-988
18. Krainer M, Silva-Arrieta S, FitzGerald MG, Shimada A, Ishioka C, Kanamaru R, MacDonald DJ, Unsal H, Finkelstein DM, Bowcock A, Isselbacher KJ and Haber DA (1997) Differential contributions of BRCA1 and BRCA2 to early-onset breast cancer. N Engl J Med 336: 1416-1421
19. Langston AA, Malone KE, Thompson JD, Daling JR and Ostrander EA (1996) BRCA1 mutations in a population-based sample of young women with breast cancer. N Engl J Med 334: 137-142
20. Li FP, Fraumeni Jr JF, Mulvihill JJ, Blattner WA, Dreyfus MG, Tucker MA and Miller RW (1988) A cancer family syndrome in twenty-four kindreds. Cancer Res 48: 5358-5362
21. Li J, Yen C, Liaw D, Podsypanina K, Bose S, Wang SI, Pue J, Miliaresis C, Rodgers L, McCombie R, Bigner SH, Giovanella BC, Ittmann M, Tycko B, Hibshoosh H, Wigler MH and Parsons R (1997) PTEN a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 275: 1943-1947
22. Malone KE, Daling JR, Thompson JD, O'Brien CA, Francisco LV and Ostrander EA (1998) BRCA1 mutations and breast cancer in the general population. JAMA 279: 922-929
23. Negri E, Braga C, Vecchia CL, Franceschi S and Parazzini F (1997) Family history of cancer and risk of breast cancer. Int J Cancer 72: 735-738
24. Newman B, Millikan RC and King M-C (1997) Genetic epidemiology of breast and ovarian cancers. Epidemiol Rev 19: 69-79
25. Olsen JH, Boice Jr JD, Seersholm N, Bautz A and Fraumeni Jr JF (1995) Cancer in parents of children with cancer. N Engl J Med 333: 1594-1599
26. Peto J, Easton DF, Matthews FE, Ford D and Swerdlow AJ (1996) Cancer mortality in relatives of women with breast cancer: the OPCS study. Int J Cancer 65: 275-283
27. Pharoah PD, Day NE, Duffy S, Easton DF and Ponder BA (1997) Family history and the risk of breast cancer: a systematic review and meta-analysis. Int J Cancer 71: 800-809
28. Rebbeck TR, Couch KJ, Kant J, Calzone K, DeShano M, Peng Y, Chen K, Garber JE and Weber BL (1996) Genetic heterogenicity in hereditary breast cancer: role of BRCA1 and BRCA2. Am J Hum Genet 59: 547-553
29. Rothman KJ and Boice Jr JD (1979) Epidemiologic Analysis with a Programmable Calcuator. DHHS publication no. (NIH) 79-1649. Government Printing Office: Washington, DC
30. Schildkraut JM, Risch N and Thompson WD (1989) Evaluating genetic association among ovarian, breast, and endometrial cancer: evidence for a breast/ovarian cancer relationship. Am J Hum Genet 45: 521-529
31. Sellers TA, Potter JD, Rich SS, Drinkard CR, Bostick RM, Kushi LH, Zheng W and Folsom AR (1994) Familial clustering of breast and prostate cancers and risk of postmenopausal breast cancer. J Natl Cancer Inst 86: 1860-1865
32. Slattery ML and Kerber RA (1993) A comprehensive evaluation of family history and breast cancer risk: the Utah Population Database. J Am Med Assoc 270: 1563-1568
33. Storm HH, Andersson M, Boice Jr JD, Blettner M, Stovall M, Mouridsen HT, Dombernowsky P, Roce C, Jacobsen A and Pedersen M (1992) Adjuvant radiotherapy and risk of contralateral breast cancer. J Natl Cancer Inst 84: 1245-1250
34. Stratton MR and Wooster R (1996) Hereditary predisposition to breast cancer. Curr Opinions Genet Dev 6: 93-97
35. Struewing JP, Tarone RE, Li F, Brody LC and Boice Jr JD (1996) BRCA1 mutations in young women with breast cancer (letter). Lancet 347: 1493
36. Struewing JP, Hartge P, Wacholder S, Baker SM, Berlin M, McAdams M, Timmerman MM, Brody LC and Tucker MA (1997) The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N Engl J Med 336: 1401-1408
37. Teare MD, Wallace SA, Harris M, Howell A and Birch JM (1994) Cancer experience in the relatives of an unselected series of breast cancer patients. Br J Cancer 70: 102-111
38. Tulinius H, Egilsson V, Olafsdottir GH and Sigvaldson (1992a) Risk of prostate, ovarian, and endometrial cancer among relatives of women with breast cancer. Br Med J 305: 855-857
39. Tulinius H, Sigvaldsson H, Olafsdottir G and Tryggvadottir L (1992b) Epidemiology of breast cancer in families in Iceland. J Med Genet 29: 158-164
40. Tulinius H, Olafsdottir GH, Sigvaldason H, Tryggvadottir L and Bjarnadottir K (1994) Neoplastic diseases in families of breast cancer patients. J Med Genet 31: 618-621
41. Varley JM, Evans DG and Birch JM (1997) Li-Fraumeni syndrome - a molecular and clinical review. Br J Cancer 76: 1-14
42. Whittemore AS, Gong G and Itnyre J (1997) Prevalence and contribution of BRCA1 mutations in breast cancer and ovarian cancer: results from three US population-based case-control studies of ovarian cancer. Am J Hum Genet 60: 496-504
43. World Health Organization (1957) Manual of the International Statistical Classification of Diseases, Injuries, and Causes of Death, 7th rev. World Health Organization: Geneva